Larvol Delta - MEK-inhibition-with-zapnometinib-as-a-treatment-for-RNA-virus-infections-The-dual-benefit-of-host-immunomodulation-and-antiviral-activity

zapnometinib (ATR-002) - Atriva Therap

https://s3.eu-central-1.amazonaws.com/eswi.org/downloads/Poster-Listing-ESWI2023.xlsx

Stephan Stenglein

Aug 30, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next